한국어 · English · 简体中文 · Русский · Bahasa Indonesia · ภาษาไทย · Tiếng Việt · 日本語

Approved ingredients

미배아발효분말(제2025-66호)

미배아발효분말(제2025-66호)

MFDS recognition no.제2025-66호
Approval routeIndividually approved (개별인정형) — only the approval holder may use this wording
Daily intake (as approved)500.0–500.0 mg/일

Approved wording (Korean original)

(국문) · 수면의 질 개선에 도움을 줄 수 있음 · 자외선에 의한 피부 손상으로부터 피부 건강 유지에 도움을 줄 수 있음 · 피부 보습에 도움을 줄 수 있음 (영문) · May help to improve sleep quality · May help to maintain skin health from skin damage by UV radiation · May help to maintain skin moisturizing

Precautions (Korean original)

(1) 영‧유아, 어린이, 임산부 및 수유부는 섭취를 피할 것 (2) 특정질환(알레르기 체질 등)이 있는 분은 섭취에 주의할 것 (3) 이상사례 발생 시 섭취를 중단하고 전문가와 상담할 것
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.